Search Results - "A. Goorhuis"

Update of treatment algorithms for Clostridium difficile infection by Ooijevaar, R.E., van Beurden, Y.H., Terveer, E.M., Goorhuis, A., Bauer, M.P., Keller, J.J., Mulder, C.J.J., Kuijper, E.J.

“…Clostridium difficile is the leading cause of antibiotic-associated diarrhoea, both in healthcare facilities and in the community. The recurrence rate of…”
Get full text

How to: Establish and run a stool bank by Terveer, E.M., van Beurden, Y.H., Goorhuis, A., Seegers, J.F.M.L., Bauer, M.P., van Nood, E., Dijkgraaf, M.G.W., Mulder, C.J.J., Vandenbroucke-Grauls, C.M.J.E., Verspaget, H.W., Keller, J.J., Kuijper, E.J.

“…Since 2013, several stool banks have been developed following publications reporting on clinical success of ‘faecal microbiota transplantation’ (FMT) for…”
Get full text

Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016 by Steinhagen, Katja, Probst, Christian, Radzimski, Christiane, Schmidt-Chanasit, Jonas, Emmerich, Petra, van Esbroeck, Marjan, Schinkel, Janke, Grobusch, Martin P, Goorhuis, Abraham, Warnecke, Jens M, Lattwein, Erik, Komorowski, Lars, Deerberg, Andrea, Saschenbrecker, Sandra, Stöcker, Winfried, Schlumberger, Wolfgang

“…Serological diagnosis of Zika virus (ZIKV) infections is challenging due to high cross-reactivity between flaviviruses. We evaluated the diagnostic performance…”
Get full text

Relatedness of Human and Animal Clostridium difficile PCR Ribotype 078 Isolates Determined on the Basis of Multilocus Variable-Number Tandem-Repeat Analysis and Tetracycline Resistance by Bakker, D, Corver, J, Harmanus, C, Goorhuis, A, Keessen, E.C, Fawley, W.N, Wilcox, M.H, Kuijper, E.J

“…Totals of 102 and 56 Clostridium difficile type 078 strains of human and porcine origins, respectively, from four European countries were investigated by an…”
Get full text

Predicting a complicated course of Clostridium difficile infection at the bedside by Hensgens, M.P.M., Dekkers, O.M., Goorhuis, A., LeCessie, S., Kuijper, E.J.

“…Clostridium difficile infections (CDIs) are a common cause of antibiotic-associated diarrhoea and associated with CDI-related mortality in c. 10%. To date,…”
Get full text

Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe by Nurjadi, D., Friedrich-Jänicke, B., Schäfer, J., Van Genderen, P.J.J., Goorhuis, A., Perignon, A., Neumayr, A., Mueller, A., Kantele, A., Schunk, M., Gascon, J., Stich, A., Hatz, C., Caumes, E., Grobusch, M.P., Fleck, R., Mockenhaupt, F.P., Zanger, P.

“…Staphylococcus aureus is emerging globally. Treatment of infections is complicated by increasing antibiotic resistance. We collected clinical data and swabs of…”
Get full text

Spread and Epidemiology of Clostridium difficile Polymerase Chain Reaction Ribotype 027/Toxinotype III in The Netherlands by Goorhuis, A., Van der Kooi, T., Vaessen, N., Dekker, F. W., Van den Berg, R., Harmanus, C., van den Hof, S., Notermans, D. W., Kuijper, E. J.

“…Background. After reports of emerging outbreaks in Canada and the United States, Clostridium difficile—associated disease (CDAD) due to polymerase chain…”
Get full text

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia by Beenen, L.F.M., Bos, L.D., Scheerder, M.J., Lobé, N.H.J., Muller, M.C.A., Schultz, M.J., van den Aardweg, J.G., Goorhuis, A., Bonta, P.I., Middeldorp, S., Vlaar, A.P.

Get full text

Monoclonal antibodies for the treatment of Ebola virus disease by Moekotte, A L, Huson, M A M, van der Ende, A J, Agnandji, S T, Huizenga, E, Goorhuis, A, Grobusch, M P

“…To date, the management of patients with suspected or confirmed Ebolavirus disease (EVD) depends on quarantine, symptomatic management and supportive care, as…”
Get more information

Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina by Goorhuis, A., Legaria, M.C., van den Berg, R.J., Harmanus, C., Klaassen, C.H.W., Brazier, J.S., Lumelsky, G., Kuijper, E.J.

“…Isolates from patients with Clostridium difficile infection (CDI) usually produce both toxin A (TcdA) and toxin B (TcdB), but an increasing number of reports…”
Get full text

COVID-19 impact on EuroTravNet infectious diseases sentinel surveillance in Europe by Grobusch, Martin P., Weld, Leisa, Schnyder, Jenny L., Larsen, Carsten Schade, Lindner, Andreas K., Popescu, Corneliu Petru, Huits, Ralph, Goorhuis, A., Gautret, Philippe, Schlagenhauf, Patricia

“…The COVID-19 pandemic resulted in a sharp decline of post-travel patient encounters at the European sentinel surveillance network (EuroTravNet) of travellers’…”
Get full text

Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature by Ooijevaar, R E, van Nood, E, Goorhuis, A, Terveer, E M, van Prehn, J, Verspaget, H W, van Beurden, Y H, Dijkgraaf, M G W, Keller, J J

“…Fecal microbiota transplantation (FMT) has become a well-established treatment for recurrent infection (rCDI). While short-term outcomes and adverse events…”
Get full text

Type-Specific Risk Factors and Outcome in an Outbreak With 2 Different Clostridium difficile Types Simultaneously in 1 Hospital by Goorhuis, A., Debast, S. B., Dutilh, J. C., van Kinschot, C. M., Harmanus, C., Cannegieter, S. C., Hagen, E. C., Kuijper, E. J.

“…Background. Clostridium difficile infection (CDI) due to polymerase chain reaction (PCR) ribotype 027 (type 027) has been described worldwide. In some…”
Get full text

Predominance of dfrG as determinant of trimethoprim resistance in imported Staphylococcus aureus by Nurjadi, D., Schäfer, J., Friedrich-Jänicke, B., Mueller, A., Neumayr, A., Calvo-Cano, A., Goorhuis, A., Molhoek, N., Lagler, H., Kantele, A., Van Genderen, P.J.J., Gascon, J., Grobusch, M.P., Caumes, E., Hatz, C., Fleck, R., Mockenhaupt, F.P., Zanger, P.

“…To investigate the global occurrence of trimethoprim–sulfamethoxazole resistance and the genetic mechanisms of trimethoprim resistance, we analysed…”
Get full text

Risk of rabies exposure among travellers by Wieten, R W, Tawil, S, van Vugt, M, Goorhuis, A, Grobusch, M P

“…In recent years, requests for rabies immunoglobulin have increased at Amsterdam's Academic Medical Center's travel clinic. Travellers who received rabies…”
Get full text

Rabies Vaccinations: Are Abbreviated Intradermal Schedules the Future? by Wieten, R. W., Leenstra, T., van Thiel, P. P. A. M., van Vugt, M., Stijnis, C., Goorhuis, A., Grobusch, M. P.

“…Rabies is a deadly disease, and current preexposure vaccination schedules are lengthy and expensive. We identified nine studies investigating abbreviated…”
Get full text

17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients by Wieten, R.W, Goorhuis, A, Jonker, E.F.F, de Bree, G.J, de Visser, A.W, van Genderen, P.J.J, Remmerswaal, E.B.M, ten Berge, I.J.M, Visser, L.G, Grobusch, M.P, van Leeuwen, E.M.M

“…Summary Background The 17D live attenuated yellow fever (YF) vaccine is contra-indicated in immune-compromised individuals and may elicit a suboptimal…”
Get full text

Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands by Hensgens, M P, Goorhuis, A, Notermans, D W, van Benthem, B H, Kuijper, E J

“…After the first outbreaks of Clostridium difficile PCR ribotype 027 (North American pulsed-field type 1, restriction endonuclease analysis group BI) in the…”
Get full text

The prevalence of peripheral arterial disease in middle-aged people with intellectual disabilities by Zaal-Schuller, I.H., Goorhuis, A.E.M., Bock-Sinot, A., Claassen, I.H.M., Echteld, M.A., Evenhuis, H.M.

“…•Peripheral arterial disease is a first sign of cardiovascular disease.•Its overall prevalence in adults with mild to severe intellectual disabilities aged…”
Get full text

Yellow fever revaccination guidelines change – a decision too feverish? by Grobusch, M.P., Goorhuis, A., Wieten, R.W., Verberk, J.D.M., Jonker, E.F.F., van Genderen, P.J.J., Visser, L.G.

Get full text